meability-surface area (PSu) in 14 patients with acute respiratory failure and pulmonary edema. All patients had increased EVLW, but EVLW in the 10 surviving patients (0.26±0.06 SE ml/ml total lung capacity [TLC]) was not significantly different from that in the five patients who died (0.22±0.05). EVLW did not correlate with intravascular pressures or with alveolararterial oxygen pressure difference (A-aDO2). PSu was lower in surviving patients (0.50±0.16 SE ml/s X liter TLC) than in patients who died (3.44±0.36; P < 0.05) and also lower than in previously reported data in patients with normal PSu. PSu correlated significantly with A-aDO2. Serial studies showed that PSu returned from a low value toward normal in a patient who survived but remained high in a patient who died. We conclude that the amount of edema in the lungs measured by indicator methods was not the principal determinant of either the magnitude of oxygenation defect or survival in the patients studied. We interpret the low PSu in surviving patients as decreased surface area and infer that the ability of the lung circulation to reduce perfusion of damaged and edematous areas was important in preserving oxygenation. A high PSu, presumably reflecting perfusion of areas with increased permeability, was a sign of especially poor INTRODUCTION Pulmonary edema is commonly associated with acute respiratory failure in humans without preexisting lung disease. In the absence of heart failure, that condition is often called the adult respiratory distress syndrome (ARDS).' Although the hypoxemia in these patients is usually attributed to edema, other abnormalities in both airway and vascular function may contribute to inadequate oxygenation (1) .
Lung edema in ARDS is thought to result from increased vascular permeability to water and proteins. However, the pathogenesis of the syndrome in humans has been largely inferred from animal studies, because there have been no techniques for measuring lung vascular permeability in living humans.
Apart from hydrostatic and oncotic pressures (the "Starling forces"), determinants of fluid and solute filtration from the intravascular space into the lung include both the permeability of exchanging vessels and their surface area (2) . There is good evidence that parallel inhomogeneities in flow resistance develop in injured lungs, so that flow to hypoxic (and edematous) regions is reduced (3) . This decreased perfusion of malfunctioning areas would reduce perfused vascular surface area. In patients with acute respiratory failure, both increased vascular permeability and decreased exchanging vessel surface area would be expected.
Several techniques for measuring vascular permeability have been used in experimental animals, including measurements of lung lymph flow and protein content (4) (5) (6) and external scanning of radiolabeled macromolecules (7) (8) . A common feature of the techniques is that the measurements do not separate permeability from exchanging vessel surface area.
Previously, we used a multiple tracer technique to measure lung water and vascular permeability-surface area in animals (9-11) and humans with chronic heart failure (12) . We now have made these measurements in patients with acute respiratory failure and pulmonary edema. We found that the severity of the gasexchange abnormality in these patients did not correlate with lung water, but did correlate with permeability-surface area for urea (PSu). These findings are consistent with the notion that decreased perfusion of injured (and therefore poorly ventilated) areas of the lung helps preserve oxygenation of systemic blood by improving the match of perfusion to ventilation and that failure of this regulatory mechanism results in more severe systemic hypoxemia. Low PSu in patients surviving acute respiratory failure suggested decreased perfused surface area and high permeability-surface area in patients dying of acute respiratory failure suggested perfusion of injured areas of the lung.
We conclude that severe hypoxemia in acute respiratory failure is due, at least in part, to a failure of the lung to decrease flow to injured areas and that this abnormality, reflected by a high permeability-surface area, is a sign of particularly bad prognosis. Permeability-surface area is lower than normal in patients with milder gas exchange abnormalities, so that the measurement may permit early diagnosis. Permeability-surface area is a more useful measurement than lung water, because it relates more closely to the gas exchange function of the lung and to severity of disease reflected in survival.
METHODS
Patient selection. We studied 14 patients with the clinical diagnosis of acute respiratory failure and pulmonary edema in the intensive care units at Vanderbilt University Hospital and Duke University Medical Center. The only criteria for acceptance into the study were an initial Pao, < 50 torr at Fio, = 0.21, multilobar infiltrates on chest radiograph, and no clinical evidence of heart failure (measurements of pulmonary artery and wedge pressures were made at the time of the study). Patients 30 blood samples were collected at 1.5-2.0-s intervals by allowing blood to flow from a radial artery cannula into heparinized tubes mounted on a precisely timed rotating disc collector. Samples were analyzed exactly as described several times in the literature (9) (10) (11) (12) (13) . Briefly, 125I and 51Cr activities were measured in a gamma spectrometer in each blood sample and a sample of the injected mixture. After ethanol precipitation, 14C and 'H activities were measured in supernatant from the same samples in a liquid scintillation counter. Corrections for isotope overlap and quenching were made.
Indicator curves were constructed for each isotope by plotting activity in each sample relative to total activity injected as a function of time after injection and the downslopes extrapolated exponentially. All curves had recoveries of injected indicator of 100±5%. We calculated cardiac output as the reciprocal of the area under the 51Cr curve (14) .
To calculate extravascular lung water and permeabilitysurface area for ['4C]urea, we constructed a composite intravascular indicator curve from 51Cr and 125I data, weighted for hematocrit and water content of erythrocytes and plasma as described by Goresky et al. (15) Using the composite intravascular reference curve in the PS.
calculation assumes that erythrocyte permeability for urea is large enough that it does not limit tracer urea exchange under the conditions of our studies.
Computation of PS,, by mathematical model analysis has been shown to be a more consistent method for computing PSu in normal patients (12) and animals (18) . However, many of the studies in the series had extractions so low that model methods were invalid. Hence, all PS,, values were computed by the Crone extraction formula for consistency.
We normalized data to predicted total lung capacity (TLC) to account for differences in lung size among patients.
Other measurements. We measured mean pulmonary artery and pulmonary artery wedge pressures through SwanGanz catheters placed in the pulmonary artery through an antecubital vein. The zero reference was the midaxillary line with patients supine. We measured Po2, Pco2, and pH in arterial blood samples collected anaerobically just before the indicator study and calculated alveolar Po2, assuming a respiratory exchange ratio of 0.8. Total protein concentrations were measured in plasma samples taken at the time of the indicator studies by a modified biuret method, and protein osmotic pressures were calculated by the equation of Landis and Pappenheimer (19) .
Statistics. Differences between groups were considered significant if P was <0.05 (unpaired t test) (20) . Correlation coefficients between variables were calculated for a straight line and for a parabola. Table I summarizes demographic and clinical data for the 14 patients studied. The spectrum of diagnoses is typical of acute respiratory failure. The patients with pneumococcal pneumonia and miliary tuberculosis were included because both had extensive bilateral infiltrates on chest radiograph and acute respiratory failure. Five of the 14 patients died of respiratory failure, a mortality rate similar to that reported in the literature (21) . Fig. 1 shows a representative set of indicator curves from one of the studies. The steeper rise and higher peak of the 51Cr-erythrocyte curve compared with that of 1251-albumin is typical of animal (9-11) and human (12) studies and presumably results from separation of plasma and erythrocytes in transit through small vessels (16 in patients with varying degrees of chronic heart failure (12) . No measurements of lung 14C_PSu have been made in normal humans, but we infer that values from patients with chronic heart failure are normal, because: (a) some patients in that series had normal pulmonary vascular pressures and cardiac output; (b) there was a linear correlation of lung 4C-PSu with lung volume in the entire group of patients, regardless of pulmonary vascular pressures; (c) 4C-PSu did not correlate with pulmonary vascular pressures in that series of studies; and (d) animal studies showed no effect of elevated left atrial pressure on lung vascular '4C_PSu.
RESULTS
Data from the five patients who died with respiratory failure and the nine patients who did not are shown separately in Fig. 2 and all of the data are nor- In contrast to patients with chronic heart failure (12), there was no correlation between lung water and the difference between lung microvascular pressure and plasma oncotic pressure (Fig. 3) . Neither was there a correlation between the amount of measured EVLW and the severity of the oxygenation defect as reflected in the A-aDO2 (Fig. 4) .
The relationship between "4C-PSu and A-aDO2 for patients with respiratory failure and pulmonary edema is shown in Fig. 5 for all of the studies. As in Fig. 2 , the normal value for '4C-PSu is from patients with chronic heart failure (12). Although there was a significant linear correlation between these two variables in the patients with respiratory failure, the relationship was described better by the parabola shown in the figure (r = 0.68, P = 0.02). The same relationship from serial studies in two patients is shown in Fig. 6 . In the patient who survived, 4C-PS,u increased toward normal as gas exchange improved. In the patient who died, 4C-PS,u remained high as did A-aDO2.
As in our earlier studies (12) (23, 24) . The patients we studied had markedly increased lung water compared both with patients with chronic heart disease studied earlier (12) and with normal subjects reported in the literature (13 Table II ).
coli endotoxin to produce respiratory failure and cause pulmonary edema without heart failure (an animal model that is pathophysiologically similar to the human syndrome), we saw no relationship between AaDO2 just before death and EVLW measured postmortem by the most accurate available methods (26) . Whether actual lung water content in the patients we studied correlated with oxygenation is unknown.
Since pulmonary edema occurs in patients with acute respiratory failure in the presence of low pulmonary arterial wedge pressure, the edema is thought to result from injury to lung exchanging vessels, so that they leak excessive fluid and protein. This assumption is supported by measurements of high protein concentrations in edema fluid from humans and by extensive studies in animal models. But we found low permeability-surface area for a small hydrophilic solute in many of our patients.
[14C]urea PS (ml/s) TLC (liter) Table II ). The normal value is from patients with chronic heart failure (12) The most logical explanation for low PSu values in many of our patients is decreased perfused vascular surface area. Since hypoxic vasoconstriction (3) and possibly other local forces (27) would be expected to reduce perfusion to edematous (and therefore poorly ventilated) areas of the lung, a decrease in perfused vascular surface area would be expected unless edema was completely uniform. We interpret the low PSu values in many of our patients as a reduction of perfusion to areas of high permeability. Since labeled water is more diffusible than urea, EVLW will not be as sensitive to such changes. Thus, some edema may be measured by labeled water, even though the damaged capillaries, which generated it, are underperfused.
In some cases, there was no measurable extraction of urea and permeability-surface area was zero. This occurs in a multiple-indicator method when flow through capillaries is so high that capillary residence time is shorter than transcapillary escape time. Thus, with high flow through fewer capillaries, extraction is zero. This implies that pulmonary hemodynamics did not permit measurement of capillary permeability-surface area. This phenomenon has been demonstrated experimentally by Snapper et al. (28) We interpret the relationship between PS,, and AaDO2 to mean that blood oxygenation in our patients depended on the ability of the lung to regulate distribution of blood flow. When perfusion could be re-duced to injured (and edematous) areas of lung, oxygenation did not deteriorate severely. But, when injured areas of the lung were perfused, either because of loss of local regulatory mechanisms (for example, hypoxic vasoconstriction) or because injury was too extensive to permit reduction of perfusion of injured areas, severe respiratory failure occurred. That the severity of oxygenation defect did not correlate with the amount of edema but did correlate with PSu suggests that loss of regulatory mechanisms may have been an important factor. This interpretation is supported by animal studies which show loss of pulmonary vasoconstriction with alveolar hypoxia following endotoxemia (30) and with pulmonary oxygen toxicity (31 One limitation of the indicator method is that it does not measure vascular permeability and surface area separately. However, no method applicable to intact organs, even in experimental animals, can separate permeability from surface area, and permeability-surface area may be more relevant clinically than either variable alone. The data in this paper would support that argument. In experimental animals, we have investigated a large number of substances as possible permeability indicators in the lung (37) . Based on that experimental work and on extensive theoretical work (19) , ['4C ]urea has emerged as the most appropriate indicator to date. The fact that in our previous studies in humans (12) and in this study, '4C-PSu did not correlate with cardiac output or hematocrit further supports the conclusion that urea is a diffusion-limited indicator and that its behavior in the lungs is unaffected by erythrocyte transport. Further, extensive theoretical and experimental studies have demonstrated that erythrocyte exchange does not invalidate permeability-surface area measurements made with our techniques (38) (39) (40) (41) (42) 
